Arbutus Biopharma Corporation · NASDAQ:ABUS
Beardsley Robert A exercised options for 131,333 Arbutus Biopharma Corporation shares (Form 4)
Traded Sep 18, 2026 · Filed Sep 23, 2026
On Sep 18, 2026, Beardsley Robert A (Director) exercised options for 131,333 Arbutus Biopharma Corporation shares at an average US$3.82 for US$502K, leaving 32,276 shares. Filed Sep 23, 2026 (Form 4).
- Options exercised
- 131,333 shares
- Price
- US$3.82 average (US$3.20 to US$4.24)
- Value
- US$502K
- Holding after
- 32,276 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Common Shares | Option exercise | 52,533 | US$3.20 | 52,533 | Direct |
| Sep 18, 2026 | Common Shares | Option exercise | 78,800 | US$4.24 | 131,333 | Direct |
| Sep 18, 2026 | Common Shares | Shares withheld for tax | 99,057 | US$5.07 | 32,276 | Direct |
Source
Related
- Arbutus Biopharma Corporation
- Beardsley Robert A
- Arbutus Biopharma Corporation shareholders
- Form 4 · Beardsley Robert A · Oct 7, 2026
- Form 4 · Androski Lindsay · Oct 7, 2026
- Form 4 · Sawhney Roger · Oct 7, 2026
- Form 4 · Nguyen Tuan · Oct 7, 2026
- Schedule 13G/A · Morgan Stanley · Oct 7, 2026
- Schedule 13D/A · Roivant Sciences Ltd. · Oct 5, 2026